# Study on the Efficacy and Safety of Tongluo Kaibi Tablets in the Treatment of Fibromyalgia Syndrome

> **NCT07708948** · PHASE4 · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 150 (actual)

## Conditions studied

- Fibromyalgia Syndrome

## Interventions

- **DRUG:** Tongluo Kaibi Tablet
- **DRUG:** Pregabalin capsule

## Key facts

- **NCT ID:** NCT07708948
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-03-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708948, "Study on the Efficacy and Safety of Tongluo Kaibi Tablets in the Treatment of Fibromyalgia Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*